Please login to the form below

Not currently logged in
Email:
Password:

treatment access

This page shows the latest treatment access news and features for those working in and with pharma, biotech and healthcare.

NICE rejects Novartis migraine treatment Aimovig

NICE rejects Novartis migraine treatment Aimovig

Haseeb Ahmad, Country President, Novartis UK. “If this decision remains unchanged patients will be denied access to the first licensed treatment specifically designed to prevent migraine in adults.”. ... Ahmad confirmed that the company would

Latest news

  • CHMP backs Sanofi’s all-oral sleeping sickness drug CHMP backs Sanofi’s all-oral sleeping sickness drug

    Fexinidazole Winthrop, as exclusively oral treatment regimen for the disease, could potentially allow quicker and wider access to treatment because distribution and administration of tablets is easier,” according to the EMA. ... year for adult patients

  • AbbVie sues NHS England over hep C procurement AbbVie sues NHS England over hep C procurement

    While the decline in deaths suggests more people are getting access to drug treatment, PHE said more needs to be done, and it urged “anyone who has ever injected drugs, even ... Meanwhile, HCV Elimination Days being held in some areas to bring together

  • NICE says no to AZ and Vifor’s rival hyperkalaemia drugs NICE says no to AZ and Vifor’s rival hyperkalaemia drugs

    Most common in patients with poor kidney function, heart failure or liver disease, hyperkalemia can be fatal, and patients have had few options for treatment until now. ... hyperkalaemia can access the treatment.

  • Allogene raises $324m from record-breaking IPO for off-the shelf CAR-Ts Allogene raises $324m from record-breaking IPO for off-the shelf CAR-Ts

    allogeneic cell therapy and the potential for greater and faster patient access,” said Belldegrun. ... Pfizer also has a 25% stake in the company, allowing Allogene access to a portfolio of treatment options, including gene editing technology.

  • Janssen’s single tablet Symtuza gains NHS England funding  Janssen’s single tablet Symtuza gains NHS England funding 

    2014. “We are delighted that NHSE has provided vital funding for this treatment option; enabling access for individuals who require a darunavir-based STR to effectively control their HIV, with the ... potential to support adherence to treatment,”

More from news
Approximately 1 fully matching, plus 190 partially matching documents found.

Latest Intelligence

  • Patient outcomes in practice: delivering value that transforms lives Patient outcomes in practice: delivering value that transforms lives

    It means we have to think big in designing programmes. We must understand how we can affect the system and improve decision-making, information, access, monitoring and treatment transitions. ... making, information, access, monitoring and treatment

  • Working with our healthcare system more closely is vital Working with our healthcare system more closely is vital

    Take a recent local NHS partnership aimed at addressing specific access and capacity issues in Southampton. ... to essential treatment, expanding and improving care for people living with a leading cause of vision loss – age-related macular

  • Simplifying HCP access to digital information Simplifying HCP access to digital information

    Streamlining identity management. As it is a highly regulated industry, most life science companies maintain rigorous registration processes for access to their branded sites and portals. ... This new standard will improve how life science companies

  • The gold standard of scientific evidence The gold standard of scientific evidence

    By randomising access to the treatment, researchers would be able to measure efficacy using robust statistical methods. ... Even social media data can be used to measure real-world treatment safety and effectiveness.

  • The real-world data conundrum The real-world data conundrum

    treatment options, access for populations in developing countries and an up-to-date evidence-base is ever increasing. ... when healthcare professionals will be able to provide the right treatment, for the right person, at the right dose, at the right time

More from intelligence
Approximately 1 fully matching, plus 37 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • SWITCHED ONcology Patient Experience Focus Group Full Discussion

    In the patient experience focus group, the discussion focused on the patient journey from pre-diagnosis right through to treatment and support. ... around treatment, access to information for both patients and hcps, patient support &wellbeing and the

  • Why heading online for scientific meetings can yield greater HCP engagement

    In the good old days, HCPs would refer to their extensive collection of journals and textbooks to refresh their memories on conditions and their relevant treatment. ... They’re ready to argue with HCP opinion, put forward their own diagnosis, and even

  • So how do you really engage with patients?

    It means potentially making changes to how treatment is administered, to reflect patient needs and make their adherence to the treatment easier and more likely. ... Along with providing support, information and resources for those affected by a condition,

  • Life at the end of the Brexit tunnel

    This will allow patients to benefit from new technologies to improve diagnosis and accelerate access to treatment. ... An Advanced Therapies Treatment Centre to develop cell and gene therapies.

  • Seven ways that digital has changed pharma marketing

    Increased patient knowledge. Not so long ago, people had very little information about their condition or the treatment options available. ... People can now access information 24-7 and engage in online communities to share knowledge and get the support

More from PMHub
Approximately 0 fully matching, plus 16 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Atlantis Healthcare

Atlantis Healthcare is a global leader in optimising patient self-management. Established in 1996, we design, develop and implement scalable solutions...

Latest intelligence

The new UK government-pharma industry pricing agreement – welcome news, but there are lessons to be learnt
...
The UK’s new five-year pricing agreement
Pharma has agreed to capped growth again – in exchange for uptake promises...
Digital applications are transforming the market access landscape
Organisations are leveraging new technology to implement a wider range of business models and, in essence, drive market access success by working smarter, faster and with greater economy....

Infographics